Meanwhile, as the prophet said, “is there no balm in Gilead?” Not this time, but there is a great deal of money. As Brian Robertson recently explained, “following the money has been the key to uncovering the corruption surrounding COVID-19; now it may be the key to providing a solution to it.”
I am glad for Gilead as well.”
That was
Dr. Clifford Lane, a deputy to National Institute of Allergy and
Infectious Diseases (NIAID) boss Dr. Anthony Fauci, in an April 29, 2020
response to Tomas Cihlar, a senior vice president at the pharmaceutical company Gilead, developer of the drug remdesivir.
As the Epoch Times
reports, recently revealed emails show Fauci and NIAID officials
“scrambled in April 2020 to answer questions about altering the
endpoint” in a trial of remdesivir. Once the drug was declared the new
standard of care for COVID-19, as Forbes reported, Gilead’s stock surged more than 16 percent in overnight trading.
More @ The Independent Institute